Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 2: Identification and optimisation of substituted 2,4-bis anilino pyrimidines

被引:56
作者
Breault, GA [1 ]
Ellston, RPA [1 ]
Green, S [1 ]
James, SR [1 ]
Jewsbury, PJ [1 ]
Midgley, CJ [1 ]
Pauptit, RA [1 ]
Minshull, CA [1 ]
Tucker, JA [1 ]
Pease, JE [1 ]
机构
[1] AstraZeneca, Macclesfield SK10 4TG, Cheshire, England
关键词
CELL-CYCLE; CDK4; INHIBITORS; DESIGN;
D O I
10.1016/S0960-894X(03)00203-8
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Through chemical modification and X-ray crystallography we identified the 2,4-bis anilino pyrimidines as potent inhibitors of CDK4. Herein, we describe the optimisation of this series. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2961 / 2966
页数:6
相关论文
共 26 条
[1]  
*ACC, INS 2
[2]  
*ACC, CNX VERS 2000 1
[3]  
*ACC, QUANTA2000
[4]   A FAST ALGORITHM FOR RENDERING SPACE-FILLING MOLECULE PICTURES [J].
BACON, D ;
ANDERSON, WF .
JOURNAL OF MOLECULAR GRAPHICS, 1988, 6 (04) :219-220
[5]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[6]   Cyclin D1 in breast cancer [J].
Barnes, DM ;
Gillett, CE .
BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) :1-15
[7]  
BEATTIE JF, IN PRESS BIOORG MED
[8]  
BREAULT GA, Patent No. 0012485
[9]   Identification of selective inhibitors of cyclin dependent kinase 4 [J].
Carini, DJ ;
Kaltenbach, RF ;
Liu, J ;
Benfield, PA ;
Boylan, J ;
Boisclair, M ;
Brizuela, L ;
Burton, CR ;
Cox, S ;
Grafstrom, R ;
Harrison, BA ;
Harrison, K ;
Akamike, E ;
Markwalder, JA ;
Nakano, Y ;
Seitz, SP ;
Sharp, DM ;
Trainor, GL ;
Sielecki, TM .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (16) :2209-2211
[10]   An extensively modified version of MolScript that includes greatly enhanced coloring capabilities [J].
Esnouf, RM .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1997, 15 (02) :132-+